World Trade Center Particulate Matter Induced Cardiorespiratory and Vascular Dysfunction: a MultiOmic Approach (CaRVD)

Recruiting Observational Study
Cardiorespiratory and Vascular Dysfunction Obstructive Airway Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
21 – 90
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
NYU Langone Health · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Particulate matter (PM) associated cardiorespiratory and vascular dysfunction (CaRVD) poses a significant global health burden. The World Trade Center (WTC) destruction on September 11, 2001 led to an intense deposition of particulate matter (WTC-PM) into aerodigestive system. WTC associated morbidities include respiratory, gastrointestinal, chronic rhinosinusitis, cancer, mental health concerns a…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Age 21-90 2. FDNY rescue and recovery worker 3. Documented WTC exposure 4. Consented/Enrolled member of the WTC-HP 5. Subjects are willing and able to consent for themselves to study enrollment 6. Subjects are willing and able to participate in study procedures 7. Are able to…
Contacts

Anna Nolan, MD

646-501-6783

Anna.nolan@nyulangone.org

CONTACT

Aida Fallah Zadeh

aida.fallahzadeh@nyulangone.org

CONTACT